# Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer

> **NCT00286819** · PHASE2 · COMPLETED · sponsor: **Central European Cooperative Oncology Group** · enrollment: 50 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** the FEC75 and 95 regimen

## Key facts

- **NCT ID:** NCT00286819
- **Lead sponsor:** Central European Cooperative Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2006-09
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286819, "Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00286819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*